Mester R, Mozes T, Spivak B, Blumensohn R, Ben-Amitay G, Kotler M
Ness-Ziona Mental Health Center, Israel.
Isr J Psychiatry Relat Sci. 2000;37(2):95-102.
The 1996 Israel Law for Patients' Rights, Sections 21 and 22, introduces to the field of health legislation two new entities: internal examination committees and quality-control committees. The former are to be established when there is a need to investigate unusual, irregular or exceptional events related to diagnosis and/or treatment. Furthermore, the 1996 Law directs the internal examination committee to reveal its findings to the patient or to his representatives. This approach has evoked strong controversy up until the present time. On the other hand, the quality-control committees which produce privileged information have been smoothly integrated into psychiatric practice. This paper presents the history of the creation of these two committees based on law, and examines their effect on the daily practice of medicine and the reaction of the physicians' guild to their activation. It also discusses the effect of the implementation of these committees on the level of mutual trust between therapist and patient, and on medical morality and its relationship to the social phenomenon known as defensive medicine. Feasible solutions for controversial issues are presented. These include participation of patients or their representatives in the internal examination committees, privileged peer reviews, increased utilization of quality control committees and of ethics committees.
1996年以色列《患者权利法》第21条和第22条在卫生立法领域引入了两个新实体:内部审查委员会和质量控制委员会。前者在需要调查与诊断和/或治疗相关的异常、不规范或特殊事件时设立。此外,1996年的法律指示内部审查委员会向患者或其代表披露调查结果。直到目前,这种做法引发了强烈争议。另一方面,产生保密信息的质量控制委员会已顺利融入精神病学实践。本文介绍了这两个委员会依法设立的历史,并考察了它们对日常医疗实践的影响以及医师协会对其启动的反应。文章还讨论了这些委员会的实施对治疗师与患者之间的互信程度、医疗道德以及它与被称为防御性医疗的社会现象之间关系的影响。文中提出了针对争议问题的可行解决方案。这些方案包括患者或其代表参与内部审查委员会、保密的同行评审、增加质量控制委员会和伦理委员会的使用。